Ocular effects of phenothiazine derivatives and reversibility.
D000065:Accommodation, Ocular / Q000187:drug effects; D000818:Animals; D002415:Cats; D002746:Chlorpromazine / Q000009:adverse effects; D003315:Cornea / Q000187:drug effects; D005128:Eye Diseases / Q000139:chemically induced*; D005260:Female; D005654:Fundus Oculi / Q000187:drug effects; D006801:Humans; D007908:Lens, Crystalline / Q000187:drug effects; D008297:Male; D010396:Penicillamine / Q000627:therapeutic use; D010640:Phenothiazines / Q000009:adverse effects*; D010859:Pigmentation Disorders / Q000139:chemically induced*; D010879:Piperazines / Q000494:pharmacology; D010880:Piperidines / Q000494:pharmacology; D012559:Schizophrenia / Q000150:complications / Q000188:drug therapy; D013881:Thioridazine / Q000009:adverse effects; D014149:Tranquilizing Agents / Q000009:adverse effects*
D010640:Phenothiazines; D010879:Piperazines; D010880:Piperidines; D014149:Tranquilizing Agents; D010396:Penicillamine; D013881:Thioridazine; D002746:Chlorpromazine